A Phase 3 Safety and Efficacy Trial of FLT201 Gene Therapy in Patients with Gaucher Disease Type 1
Clinical Trial Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Spur Therapeutics Limited
Start Date
February 10, 2026
End Date
August 1, 2034
Administered By
Pediatrics, Medical Genetics
Awarded By
Spur Therapeutics Limited
Start Date
February 10, 2026
End Date
August 1, 2034